Atorvastatin
A high-intensity statin that lowers LDL cholesterol by 40–60% and reduces the risk of heart attack and stroke in high-risk patients.
How It Works
Atorvastatin competitively inhibits HMG-CoA reductase, the enzyme that controls the rate-limiting step in hepatic cholesterol synthesis. Reduced intracellular cholesterol prompts liver cells to upregulate LDL receptors on their surface, pulling LDL particles from the bloodstream for processing. The net result is a substantial reduction in circulating LDL — the primary driver of atherosclerotic plaque.
Atorvastatin also has pleiotropic effects beyond LDL lowering: it reduces vascular inflammation, stabilizes existing plaques (lowering rupture risk), and improves endothelial function. Its long half-life (~14 hours, with active metabolites persisting 20–30 hours) makes it effective regardless of the time of day it is taken.
Common Uses
- Primary hyperlipidemia and mixed dyslipidemia
- Cardiovascular event prevention (primary and secondary)
- Familial hypercholesterolemia (adults and children ≥10 years)
- Elevated triglycerides
- Diabetes with cardiovascular risk factors (age ≥40)
Common Side Effects
- Muscle pain or weakness (myalgia) — the most common reason patients discontinue; bilateral and involving large muscle groups
- Headache and nasopharyngitis
- Nausea, diarrhea, constipation
- Transient liver enzyme (transaminase) elevation — usually mild and reversible
- Modest increase in new-onset diabetes risk in predisposed patients
- Rhabdomyolysis (rare but serious) — severe muscle breakdown with myoglobinuria; risk greatly elevated by interacting drugs
Warnings & Precautions
BLACK BOX / SERIOUS: Statins can cause myopathy progressing to rhabdomyolysis. Report unexplained muscle pain, weakness, or dark/cola-colored urine immediately. Risk is sharply increased by cyclosporine, strong CYP3A4 inhibitors (clarithromycin, itraconazole), and gemfibrozil.
- Grapefruit interaction: Large quantities inhibit CYP3A4 and raise atorvastatin levels — avoid regular consumption of grapefruit juice in large amounts
- Pregnancy: Contraindicated — statins inhibit the mevalonate pathway required for fetal development; use effective contraception
- Active liver disease: Contraindicated in unexplained persistent transaminase elevations
- Caution in elderly patients, those with renal or hepatic impairment, hypothyroidism, or low body mass — higher myopathy risk
- Avoid combination with gemfibrozil; fenofibrate is a safer fibrate alternative if needed
Common Pill Imprints
Atorvastatin tablets are elliptical (oval). Lipitor brand tablets carry "PD" imprints; generics vary by manufacturer.
| Imprint | Strength | Manufacturer | Description |
|---|---|---|---|
| PD 155 10 | 10 mg | Pfizer (Lipitor) | White elliptical tablet |
| PD 156 20 | 20 mg | Pfizer (Lipitor) | White elliptical tablet |
| PD 157 40 | 40 mg | Pfizer (Lipitor) | White elliptical tablet |
| APO 040 A | 40 mg | Apotex (generic) | White elliptical tablet |
Frequently Asked Questions
Yes. Atorvastatin's long half-life and active metabolites provide around-the-clock effect regardless of timing. Take it consistently at the same time each day. Avoid large, regular amounts of grapefruit juice.
Report unexplained muscle pain, tenderness, or weakness — especially if bilateral or accompanied by dark urine — to your healthcare provider promptly. Do not stop abruptly without guidance. A CK level check and possible therapy adjustment may be needed.
Grapefruit contains furanocoumarins that inhibit intestinal CYP3A4, raising atorvastatin blood levels. Large regular amounts meaningfully increase side-effect risk. Occasional small amounts are generally acceptable, but consistent large quantities should be avoided.
No. Atorvastatin is contraindicated in pregnancy. The mevalonate pathway it inhibits is essential for fetal development. Discuss contraception and pre-conception planning with your provider.